MDI

IQVIA Medical Data Index

Delivering real world data insights on treatment trends for diseases managed within UK general practices.

Locations United Kingdom Solutions Life Sciences Industry Solutions Market Intelligence IQVIA Medical Data Index (MDI)

IQVIA Medical Data Index provides life sciences companies with an overall market view on UK primary care diagnoses and treatments patterns. It is a quarterly summary of general practice (GP) prescribing data linked to a diagnosis, which delivers insights on what products are prescribed to treat diseases and enables monitoring of UK primary care prescribing trends.

This intelligence supports patient and disease profiling, monitoring trends in prescribing, indication splits and opportunity assessment.

What is IQVIA Medical Data Index?

Medical Data Index covers the UK primary care market, providing an overall view, ideally placed for looking at trends and benchmarking
It includes standard metrics and reporting of prescriptions volumes by diagnosis and patient age/gender, which offers diagnosis and patient profiles
It enables analysis of treatment dynamics, with information on drug form, strength, doses and quantities together with indicators new, switch, repeat

150 general practices

Panel of 150 general practices representative of the UK

310 million prescriptions

Over 310 million nationally projected prescriptions each quarter

3 years of data

3 years of history data updated quarterly

Full access

Full access to aggregated data for all drug and diagnosis classes or class specific access

Why use IQVIA Medical Data Index?

Monitor own products and competitor’s performance
Understand national level trends in prescribing
Gain insights on real world medicines used to treat which diseases
Analyse market dynamics such as new, switch, repeat, to track commercial performance
Identify commercial opportunities such as new pack sizes.

IQVIA Medical Data Index (MDI) can provide key insights into the treatment of disease within general practices in the UK.

Data capture and methodology

IQVIA Medical Data Index uses:

A representative panel of approximately 700 GPs from 150 UK general practices projected to regional and national figures
The diagnosis made by the doctor and relates it to the specific therapy prescribed and the type of patient being treated
A standardised classification of diagnoses and products bridged to the WHO ICD 10 diagnosis and EPhMRA ATC therapy classifications

MDI Fact Sheet

Related offerings

IQVIA Medical Research Data (IMRD) – is a large longitudinal primary care database used for retrospective medical and scientific research
Longitudinal Patient data (LPD) – is a longitudinal dataset of anonymised electronic health records used to generate national level insights into UK primary care prescribing patterns and disease management
MIDAS^® – country level audits of medical data (MDI) used for measuring global pharma performance
IQVIA Longitudinal Prescription Data (LRx) – an anonymised longitudinal pharmacy dispensation dataset, used for tracking patient prescription activity with the ability to drill down to sub-national data
Prescription Based Services (PBS) - consists of retail pharmacy dispensing data available at national and sub national level used for measuring demand for medicines.

DOWNLOAD

Market Intelligence Solutions

Powered by IQVIA's Information Offerings, our healthcare market intelligence solutions provides key summary data and actionable insights covering medicines and healthcare products in primary care, secondary care and supply chains across the UK, NHS and healthcare sectors.

LEARN MORE

MDI